LENSAR (LNSR) Competitors

AVITA Medical (NASDAQ:RCEL) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, community ranking, dividends and institutional ownership.

Which has more volatility & risk, RCEL or LNSR?

AVITA Medical has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500. Comparatively, LENSAR has a beta of 0.59, suggesting that its stock price is 41% less volatile than the S&P 500.

Do insiders & institutionals have more ownership in RCEL or LNSR?

27.7% of AVITA Medical shares are owned by institutional investors. Comparatively, 40.2% of LENSAR shares are owned by institutional investors. 1.8% of AVITA Medical shares are owned by company insiders. Comparatively, 38.5% of LENSAR shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Is RCEL or LNSR more profitable?

LENSAR has a net margin of -34.03% compared to AVITA Medical's net margin of -95.47%. LENSAR's return on equity of -49.02% beat AVITA Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AVITA Medical	-95.47%	-194.69%	-60.67%
LENSAR	-34.03%	-49.02%	-21.12%

Do analysts recommend RCEL or LNSR?

AVITA Medical presently has a consensus target price of $16.50, indicating a potential upside of 26.44%. LENSAR has a consensus target price of $8.00, indicating a potential upside of 9.89%. Given AVITA Medical's higher possible upside, equities analysts plainly believe AVITA Medical is more favorable than LENSAR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AVITA Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
LENSAR	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community favor RCEL or LNSR?

AVITA Medical received 69 more outperform votes than LENSAR when rated by MarketBeat users. Likewise, 67.89% of users gave AVITA Medical an outperform vote while only 38.46% of users gave LENSAR an outperform vote.

Company	Underperform	Outperform
AVITA Medical	Outperform Votes 74 67.89%	Underperform Votes 35 32.11%
LENSAR	Outperform Votes 5 38.46%	Underperform Votes 8 61.54%

Does the media prefer RCEL or LNSR?

In the previous week, LENSAR had 1 more articles in the media than AVITA Medical. MarketBeat recorded 1 mentions for LENSAR and 0 mentions for AVITA Medical. LENSAR's average media sentiment score of 1.87 beat AVITA Medical's score of 0.00 indicating that LENSAR is being referred to more favorably in the news media.

Company	Overall Sentiment
AVITA Medical	Neutral
LENSAR	Very Positive

Which has preferable valuation and earnings, RCEL or LNSR?

LENSAR has lower revenue, but higher earnings than AVITA Medical. AVITA Medical is trading at a lower price-to-earnings ratio than LENSAR, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AVITA Medical	$50.14M	6.82	-$35.38M	-$2.23	-5.85
LENSAR	$42.16M	2.00	-$14.38M	-$1.46	-4.99

Summary

LENSAR beats AVITA Medical on 11 of the 17 factors compared between the two stocks.